𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nasal administration of a novel recombinant human parathyroid hormone (1–34) analog for the treatment of osteoporosis of ovariectomized rats

✍ Scribed by Xiaoming Shi; Chunxiao Wang; Zhihua Zhuang; Jingning Lu; Jingjing Liu; Jie Wu; Rongyue Cao; Taiming Li

Book ID
113873816
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
791 KB
Volume
170
Category
Article
ISSN
0167-0115

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maintaining bone mass by bisphosphonate
Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats
✍ Yuichi Takano; Tatsuhiko Tanizawa; Tasuku Mashiba; Naoto Endo; Saburo Nishida; H 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 791 KB

Intermittent treatment with human parathyroid hormone (1-34) ] stimulates bone formation and increases cancellous bone mass in ovariectomized (OW) rats. But PTH-induced cancellous bone rapidly disappears upon cessation of treatment. The fate of cortical bone treated by PTH has not been well characte

Six-Month Daily Administration of Parath
Six-Month Daily Administration of Parathyroid Hormone and Parathyroid Hormone—Related Protein Peptides to Adult Ovariectomized Rats Markedly Enhances Bone Mass and Biomechanical Properties: A Comparison of Human Parathyroid Hormone 1–34, Parathyroid Hormone-Related Protein 1–36, and SDZ-Parathyroid Hormone 893
✍ A. F. Stewart; R. L. Cain; D. B. Burr; D. Jacob; C. H. Turner; J. M. Hock; Marc 📂 Article 📅 2000 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 655 KB